Here is the original post: Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
Here is the original post: Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
Read this article: Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
Original post: SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference
Link: Sparian Biosciences Announces Results from the Phase 1 Clinical Trial of First in Class Novel Arylepoxamide Receptor (AEAr) Agonist Analgesic SBS-1000
Continued here: Kineta Updates KVA12123 Clinical Results from Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer (2024)
Original post: CervoMed Awarded the Prix Galien USA 2024 Prize for Best Startup
Read the original here: Medigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024
Follow this link: Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2024
Read the original: Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for...
Here is the original post: Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Recent Comments